Publicacións (22) Publicacións de Luis Ignacio Sanchez-Abarca Bernal

filter_list

2018

  1. Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 12, Núm. 3, pp. e1450-e1460

  2. Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability

    Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 443-451

  3. Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib

    Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485

  4. Selection of tumor-specific cytotoxic T lymphocytes in acute myeloid leukemia patients through the identification of T-cells capable to establish stable interactions with the leukemic cells: "Doublet technology"

    Frontiers in Immunology, Vol. 9, Núm. SEP

2017

  1. Assessment of dry eye in a GVHD murine model: Approximation through tear osmolarity measurement

    Experimental Eye Research, Vol. 154, pp. 64-69

  2. Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo

    International Journal of Cancer, Vol. 140, Núm. 3, pp. 674-685

  3. HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?

    Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202

  4. Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. Caspase-8 inhibition represses initial human monocyte activation in septic shock model

    Oncotarget, Vol. 7, Núm. 25, pp. 37456-37470

  2. Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under lendex: A longitudinal analysis

    Blood, Vol. 127, Núm. 9, pp. 1151-1162

  3. Immunomodulatory effect of Vitamin D after allogeneic stem cell transplantation: Results of a prospective multicenter clinical trial

    Clinical Cancer Research, Vol. 22, Núm. 23, pp. 5673-5681

  4. MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry

    Cell Communication and Signaling, Vol. 14, Núm. 1

  5. Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients

    PLoS ONE, Vol. 11, Núm. 2

  6. Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion

    Cell Death and Disease, Vol. 7, Núm. 12

  7. The dynamics of the human leukocyte antigen head domain modulates its recognition by the T-cell receptor

    PLoS ONE, Vol. 11, Núm. 4

2015

  1. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles

    Leukemia Research, Vol. 39, Núm. 8, pp. 921-924

  2. Evaluation of a method for murine monocyte isolation by bone marrow depletion

    Analytical Biochemistry, Vol. 480, pp. 42-48

  3. Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice

    Cell Transplantation, Vol. 24, Núm. 12, pp. 2423-2433

  4. Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells

    American Journal of Cancer Research, Vol. 5, Núm. 1, pp. 386-395

  5. PTPN13 and β-catenin regulate the quiescence of hematopoietic stem cells and their interaction with the bone marrow niche

    Stem Cell Reports, Vol. 5, Núm. 4, pp. 516-531